Intensive vs. standard treatment of hyperglycemia and functional outcome in patients with acute ischemic stroke: The SHINE randomized clinical trial

Karen Johnston, Askiel Bruno, Qi Paul et al. JAMA. 2019;322(4):326–335.
      Emergency Medicine Physicians are often the first to evaluate and treat patients with acute ischemic strokes. Clinical outcomes decline when there is associated hyperglycemia and thus hyperglycemic control is crucial. There are few studies however, that demonstrate a favorable association between aggressive blood glucose control and clinical outcome compared to standard glucose control.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Journal of Emergency Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect